Ascorbic Acid Injection

[03 September 2014]

Products Affected - Description

Ascorbic acid injection, American Regent
500 mg/mL, 50 mL vial (NDC 00517-5050-01)

Reason for the Shortage

  • American Regent has ascorbic acid injection on shortage due to manufacturing delays.
  • Hospira has discontinued all presentations of Cenolate injection and all supplies were depleted as of early-February, 2010.

Available Products

Ascorbic acid injection, Mylan Institutional
500 mg/mL, 50 mL vial (NDC 67457-0118-50)

Estimated Resupply Dates

American Regent has ascorbic acid injection on a long term back order and the company cannot estimate a release date.


September 3, 2014; June 2, 2014; February 26, 2014; January 2, 2014; October 28, 2013; August 22, 2013; June 24, 2013; April 29, 2013; February 27, 2013; November 28, 2012; August 21, 2012; June 19, 2012; April 10, 2012; February 3, 2012; December 14, 2011; November 9, 2011; September 28, 2011; August 17, 2011; July 20, 2011; June 23, 2011; May 17, 2011; April 29, 2011; March 24, 2011; February 4, 2011; December 29, 2010; November 24, 2010; October 20, 2010; October 11, 2010; August 16, 2010; June 16, 2010; April 13, 2010; March 17, 2010; February 26, 2010, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.


This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.